Using antibiotics responsibly: Are we there yet?

Future Microbiology

Volumn 11, Issue 8, 2016, Pages 1057-1071

  Dyar, Oliver James ^a   Obua, Celestino ^b   Chandy, Sujith ^a,c   Xiao, Yonghong ^d   Stålsby Lundborg, Cecilia ^a   Pulcini, Céline ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^c India   (India)

^d ZHEJIANG UNIVERSITY   (China)

^e UNIVERSITÉ DE LORRAINE   (France)

Author keywords

antibiotic stewardship; antimicrobial resistance; complexity

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DRUG USE; HEALTH CARE ACCESS; HEALTH EDUCATION; HOLISTIC CARE; HUMAN; MEDICATION THERAPY MANAGEMENT; NONHUMAN; OUTPATIENT; PATIENT MONITORING; PRIORITY JOURNAL; PROGRAM SUSTAINABILITY; RESPONSIBILITY; REVIEW; BACTERIAL INFECTIONS; BACTERIUM; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIOLOGY; PHYSICIAN; PSYCHOLOGY; SOCIAL BEHAVIOR;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; PHYSICIANS; PRACTICE PATTERNS, PHYSICIANS'; SOCIAL RESPONSIBILITY;

EID: 84982111959     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2016-0041     Document Type: Review

References (61)

1. Laxminarayan R, Matsoso P, Pant S et al. Access to effective antimicrobials: a worldwide challenge. Lancet 387(10014), 168-175 (2015).
2. Mendelson M, Røttingen JA, Gopinathan U et al. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet 387(10014), 188-198 (2015).
3. Laxminarayan R. Antibiotic effectiveness: balancing conservation against innovation. Science 345(6202), 1299-1301 (2014).
4. Sachs JD. From millennium development goals to sustainable development goals. Lancet 379(9832), 2206-2211 (2012).
5. DRIVE-AB. Driving reinvestment in R&D for antibiotics and advocating their responsible use. http://drive-ab.eu
6. Oxford English Dictionary. www.oed.com
7. Dellit TH, Owens RC, McGowan JE et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44(2), 159-177 (2007).
8. British Society for Antimicrobial Chemotherapy. Practical guide to antimicrobial stewardship in hospitals. http://bsac.org.uk
9. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J. Antimicrob. Chemother. 58(2), 401-407 (2006).
10. Charani E, Castro-Sanchez E, Sevdalis N et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of 'prescribing etiquette'. Clin. Infect. Dis. 57(2), 188-196 (2013).
11. Yi H, Miller G, Zhang L, Li S, Rozelle S. Intended and unintended consequences of China's zero markup drug policy. Health Aff. (Millwood) 34(8), 1391-1398 (2015).
12. Deschepper R, Grigoryan L, Lundborg CS et al. Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv. Res. 8, 123 (2008).
13. Leibovici L, Paul M, Ezra O. Ethical dilemmas in antibiotic treatment. J. Antimicrob. Chemother. 67(1), 12-16 (2012).
14. Littmann J, Viens A. The ethical significance of antimicrobial resistance. Public Health Ethics 8(3), 209-224 (2015).
15. WHO. Global action plan on antimicrobial resistance: draft resolution with amendments resulting from informal consultations (2015). http://apps.who.int
16. Årdal C, Outterson K, Hoffman SJ et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet 387(10015), 296-307 (2015).
17. Hardin G. The tragedy of the commons. Science 162, 1243-1248 (1968).
18. Levin BR. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis. 33(Suppl. 3), S161-S169 (2001).
19. Foster KR, Grundmann H. Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLoS Med. 3(2), e29 (2006).
20. Hollis A, Maybarduk P. Antibiotic resistance is a tragedy of the commons that necessitates global cooperation. J. Law. Med. Ethics. 43(Suppl. 3), 33-37 (2015).
21. Levin BR, Baquero F, Johnsen PJ. A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its future. Curr. Opin. Microbiol. 19, 83-89 (2014).
22. Porco TC, Gao D, Scott JC et al. When does overuse of antibiotics become a tragedy of the commons? PLoS ONE 7(12), e46505 (2012).
23. Gao D, Lietman TM, Porco TC. Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting. Math. Biosci. 263, 121-132 (2015).
24. Baquero F, Campos J. The tragedy of the commons in antimicrobial chemotherapy. Rev. Esp. Quimioter. 16(1), 11-13 (2003).
25. Meadows D. Thinking in Systems: A Primer. Chelsea Green Publishing, VT, USA (2008).
26. Davey P, Brown E, Charani E et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev. 4, CD003543 (2013).
27. Grave K, Torren-Edo J, Muller A, Greko C, Moulin G, Mackay D. Variations in the sales and sales patterns of veterinary antimicrobial agents in 25 European countries. J. Antimicrob. Chemother. 69(8), 2284-2291 (2014).
28. van de Sande-Bruinsma N, Grundmann H, Verloo D et al. Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis. 14(11), 1722-1730 (2008).
29. Zinsstag J, Schelling E, Waltner-Toews D, Tanner M. From 'one medicine' to 'one health' and systemic approaches to health and well-being. Prev. Vet. Med. 101(3-4), 148-156 (2011).
30. Journals.plos.org. http://journals.plos.org
31. Francino MP. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front. Microbiol. 6, 1543 (2015).
32. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340, c2096 (2010).
33. The World Bank. World Development Indicators (2014). http://databank.worldbank.org/data
34. Grigoryan L, Monnet DL, Haaijer-Ruskamp FM, Bonten MJM, Lundborg S, Verheij TJM. Self-medication with antibiotics in Europe: a case for action. Curr. Drug Saf. 5(4), 329-332 (2010).
35. Chandy SJ, Mathai E, Thomas K, Faruqui AR, Holloway K, Lundborg CS. Antibiotic use and resistance: perceptions and ethical challenges among doctors, pharmacists and the public in Vellore, South India. Indian J. Med. Ethics 10(1), 20-27 (2013).
36. Bardhan P. The state of health services in China and India: a larger context. Health Aff. (Millwood) 27(4), 933-936 (2008).
37. Ministry of Health and Family Welfare Government of India. Notification GSR 588E (2013). www.mohfw.nic.in
38. Ocan M, Bwanga F, Bbosa GS et al. Patterns and predictors of self-medication in northern Uganda. PLoS ONE 9(3), e92323 (2014).
39. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy 90(1), 32-36 (2009).
40. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med. 10(11), e1001556 (2013).
41. Ministry of Health Republic of Uganda. Essential medicines and health supplies list for Uganda. (2012). www.medicinestransparency.org
42. Ministry of Health and Family Welfare Government of India. National list of essential medicines of India (2011). http://pharmaceuticals.gov.in
43. Song Y, Bian Y, Petzold M, Li L, Yin A. The impact of China's national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces. BMC Health Serv. Res. 14(1), 507 (2014).
44. Kotwani A, Ewen M, Dey D et al. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J. Med. Res. 125(5), 645-654 (2007).
45. Pulcini C, Bush K, Craig WA et al. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin. Infect. Dis. 54(2), 268-274 (2012).
46. Ministry of Health of China. Administrative regulations of clinical use of antibiotics. www.moh.gov.cn
47. Li J, Chen L, Luo Y, Wang G, Ye H. Comparison of antibiotic use before and after the antibiotic special campaign (Chinese). Her. Med. 32(6), 802-804 (2013).
48. Lin H, Dyar OJ, Rosales-Klintz S et al. Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009-14. J. Antimicrob. Chemother. 71(6), 1723-1729 (2016).
49. Ministére Des Affaires Sociales Et De La Santé. Plan antibiotiques. www.plan-antibiotiques.sante.gouv.fr
50. Ministére Des Affaires Sociales Et De La Santé. Rapport du groupe de travail special pour la préservation des antibiotiques. Propositions du groupe de travail spécial pour la préservation des antibiotiques: Tous ensemble, sauvons les antibiotiques (2015). http://social-sante.gouv.fr
51. Chandy SJ, Michael JS, Veeraraghavan B, Abraham OC, Bachhav SS, Kshirsagar NA. ICMR programme on antibiotic stewardship, prevention of infection & control (ASPIC). Indian J. Med. Res. 139(2), 226-230 (2014).
52. Ghafur A. The Chennai Declaration: a solution to the antimicrobial resistance problem in the Indian subcontinent. Clin. Infect. Dis. 56(8), 1190 (2013).
53. Ministry of Health Republic of Uganda. Uganda clinical guidelines: National Guidelines for Management of Common Conditions (2012). http://apps.who.int
54. Chandy SJ, Naik GS, Charles R et al. The impact of policy guidelines on hospital antibiotic use over a decade: a segmented time series analysis. PLoS ONE 9(3), e92206 (2014).
55. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet. Infect. Dis. 13(3), 189-191 (2013).
56. Wang S, Pulcini C, Rabaud C, Boivin J-M, Birgé J. Inventory of antibiotic stewardship programs in general practice in France and abroad. Medecine Mal. Infect. 45(4), 111-123 (2015).
57. Ministére Des Affaires Sociales Et De La Santé. Consommation d'antibiotiques et résistance aux antibiotiques en France. http://ansm.sante.fr
58. Robert J, Péan Y, Varon E et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J. Antimicrob. Chemother. 67(4), 1020-1026 (2012).
59. Ministére Des Affaires Sociales Et De La Santé. ICATB.2. http://social-sante.gouv.fr
60. Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby Lundborg C. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J. Antimicrob. Chemother. 68(1), 229-236 (2013).
61. Uganda National Academy of Sciences. Global antibiotic resistance partnership-Uganda (GARP-UG) launch report (2014). http://ugandanationalacademy.org